Genentech is a biotechnology company that uses cutting-edge science to discover, develop, and distribute commercialized medicine around the globe. The company is on a mission to find solutions for patients who are dealing with life-threatening medical conditions.
115 Reviews
Great mission to save people’s lives; nice campus and great wlb
Politics are prevalent; less collaboration with teams and slow pace of production
A report on two patients with late-onset neutropenia resulted in an uncommon adverse event following antiCD20 therapies.
ORIC is a speculative Buy. Key risks include disappointing data for phase 1 readouts 1H23, delays in the clinic and heavy competition in certain areas. Read more.
Seeking Alpha
